ACCEL Lite: Pulmonary Hypertension Associated with Left Heart Disease: Clinical Presentations, Implications for the RV and Treatment Targets

Pulmonary hypertension (PH) is most commonly linked to left heart disease (LHD). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force reviewed newly reported randomized clinical trial results and explored novel strategies to enhance patient outcomes. Their findings uncovered key data essential for improving clinical care.

In this interview, Drs. William Boden and Bradley Maron discuss the latest advancements in managing pulmonary hypertension caused by left heart disease.

Related References:

  1. Maron BA, Bortman G, De Marco T, et al. Pulmonary hypertension associated with left heart disease. Eur Respir J 2024;64:2401344.

Clinical Topics: Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Pulmonary Hypertension, Hypertension

Keywords: ACCELLite, Hypertension, Pulmonary, AHA24